NK cells contribute to resistance to anti-PD1 therapy in immune-excluded melanomas
E. Landeloos, J. Pozniak, N. Roda, A. de Visscher, A. Antoranz, Y. van Herck, G. Bervoets, F. M. Bosisio, V. Boecxstaens, A. Bassez, D. Lambrechts, P. Matthys, O. Bechter, J.-C. Marine
The paper identifies NK cells as contributors to resistance to anti-PD1 therapy in immune-excluded melanomas using single-cell RNA sequencing and spatial proteomics.
bioRxiv · Dec 14, 2023 · PreprintCancer Biology